Ezgi Ersoy Yeşi̇l
Research Subjects
Research Interests
Ezgi Ersoy Yeşi̇l has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Zeki Toprak
Department of Nephrology, University of Health Sciences, Umraniye Education and Research Hospital, İstanbul, Türkiye
2 shared publications - Özlem Pehlivan
Department of Rheumatology, Ümraniye Training and Research Hospital, İstanbul, Turkey
2 shared publications - Abbas Heval Demirkol1 shared publication
- Abdurrahman Koç
Department of Pulmonary Diseases, Meram State Hospital, Konya, Türkiye
1 shared publication - Atakan Yeşil
Department of Gastroenterology, Haydarpaşa Numune Education and Research Hospital, Istanbul, Turkey
1 shared publication - Atalay Surardamar1 shared publication
Latest Publications
- Open Access
- 3 September 2023
- Published by The European Research Journal in The European Research Journal
- Vol. 9 (5) , 940-947
Musculoskeletal pain and quality of life in patients undergoing hemodialysis: a single-center study
Objectives: In this study, we aimed to research the frequency of musculoskeletal manifestations of patients receiving hemodialysis treatment, and evaluate the relationship between quality of life and musculoskeletal manifestations of these patients. Methods: Patients undergoing hemodialysis for at least 6 months were included in our study. Patients were asked to complete a questionnaire that formed by the investigators including demographic, clinical features, and musculoskeletal symptoms that frequently seen in patients who receive hemodialysis. Kidney Disease Quality of Life Short Form Version 1.3 (KDQOL-SF 1.3) and Short Form Health Survey (SF 36) questionnaires were completed by the patients and the control group. Blood urea nitrogen, serum creatinine, serum albumin, C-reactive protein (CRP), parathormone (PTH), ferritin, calcium, phosphate, hemoglobin, and Kt/V were measured. Also, the patients were divided into two subgroups according to musculoskeletal symptoms and these subgroups were compared in terms of dialysis adequacy, quality of life scoring and laboratory findings. Results: Seventy-four patients (42 males, 32 females) were enrolled in our study. The mean age of the patients was 60.85 ± 12.29 years. Six-five (87.83%) patients had musculoskeletal symptoms. There was statistically major difference in terms of smoking between subgroups (p = 0.046). We did not detect any correlation between two groups in terms of Kt/V (p = 0.411). Pain in shoulder/neck (41.9%), pain in limbs (58.1%) and pain in back (56.8%) were the most detected musculoskeletal symptoms of the patients. There was statistically significant difference between genders in terms of joint swelling, muscle cramps, pain in limbs, back and neck /shoulder (p = 0.015, p = 0.001, p = 0.008, p = 0.001, and p = 0.004, respectively). We detected that all subunits of KDQOL scores were higher in control group than patients who were included in our study. There was statistically significant relation between emotional role and energy subunits of KDQOL scores and CRP (p = 0.031 and p = 0.025, respectively). Conclusion: The results of our study were not as significant as the results of similar studies, however they are valuable because they show demographic, clinical characteristics, and quality of life of patients receiving hemodialysis in our region.
- 3 September 2023
- Published by The European Research Journal in The European Research Journal
- Vol. 9 (5) , 940-947
Open AccessMusculoskeletal pain and quality of life in patients undergoing hemodialysis: a single-center study
Objectives: In this study, we aimed to research the frequency of musculoskeletal manifestations of patients receiving hemodialysis treatment, and evaluate the relationship between quality of life and musculoskeletal manifestations of these patients. Methods: Patients undergoing hemodialysis for at least 6 months were included in our study. Patients were asked to complete a questionnaire that formed by the investigators including demographic, clinical features, and musculoskeletal symptoms that frequently seen in patients who receive hemodialysis. Kidney Disease Quality of Life Short Form Version 1.3 (KDQOL-SF 1.3) and Short Form Health Survey (SF 36) questionnaires were completed by the patients and the control group. Blood urea nitrogen, serum creatinine, serum albumin, C-reactive protein (CRP), parathormone (PTH), ferritin, calcium, phosphate, hemoglobin, and Kt/V were measured. Also, the patients were divided into two subgroups according to musculoskeletal symptoms and these subgroups were compared in terms of dialysis adequacy, quality of life scoring and laboratory findings. Results: Seventy-four patients (42 males, 32 females) were enrolled in our study. The mean age of the patients was 60.85 ± 12.29 years. Six-five (87.83%) patients had musculoskeletal symptoms. There was statistically major difference in terms of smoking between subgroups (p = 0.046). We did not detect any correlation between two groups in terms of Kt/V (p = 0.411). Pain in shoulder/neck (41.9%), pain in limbs (58.1%) and pain in back (56.8%) were the most detected musculoskeletal symptoms of the patients. There was statistically significant difference between genders in terms of joint swelling, muscle cramps, pain in limbs, back and neck /shoulder (p = 0.015, p = 0.001, p = 0.008, p = 0.001, and p = 0.004, respectively). We detected that all subunits of KDQOL scores were higher in control group than patients who were included in our study. There was statistically significant relation between emotional role and energy subunits of KDQOL scores and CRP (p = 0.031 and p = 0.025, respectively). Conclusion: The results of our study were not as significant as the results of similar studies, however they are valuable because they show demographic, clinical characteristics, and quality of life of patients receiving hemodialysis in our region.
- Open Access
- 5 April 2023
- Published by Academician Publishing
Güncel Genel Dahiliye Çalışmaları V
Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2700’ü aşkın kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir. Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.
- 5 April 2023
- Published by Academician Publishing
Open AccessGüncel Genel Dahiliye Çalışmaları V
Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2700’ü aşkın kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir. Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.
- Open Access
- 20 January 2023
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 5 (1) , 18-23
Alexithymia; an often missed condition prevelant in the practice of nephrology
Aim: Alexithymia is a disorder associated with difficulty in recognizing and expressing feelings, which can lead to an increased susceptibility to disease development that makes alexithymia a possible risk factor for chronic kidney disease (CKD). This study was performed to evaluate for alexithymia in pre-dialysis CKD and end-stage renal disease patients undergoing hemodialysis. Material and Method: The study was conducted in the Nephrology Outpatient Department and Hemodialysis unit of Ümraniye Research and Training Hospital. The patients had to have a diagnosis of CKD. Demographic data form, routine biochemical follow up data of patients, Toronto Alexithymia Scale (TAS), and Hospital Depression and Anxiety Scale (HADS) were used in this study. The statistical significance level was determined as p0.05). The results showed that increased incidence of depression resulted in a 4.47-fold (p=0.035) increase in the incidence of alexithymia. Conclusion: Alexithymia has been found to be high in patients with chronic kidney disease. Therefore, it is essential that we be aware of patients’ emotional stress and assess them for depression, anxiety, and alexithymia.
- 20 January 2023
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 5 (1) , 18-23
Open AccessAlexithymia; an often missed condition prevelant in the practice of nephrology
Aim: Alexithymia is a disorder associated with difficulty in recognizing and expressing feelings, which can lead to an increased susceptibility to disease development that makes alexithymia a possible risk factor for chronic kidney disease (CKD). This study was performed to evaluate for alexithymia in pre-dialysis CKD and end-stage renal disease patients undergoing hemodialysis. Material and Method: The study was conducted in the Nephrology Outpatient Department and Hemodialysis unit of Ümraniye Research and Training Hospital. The patients had to have a diagnosis of CKD. Demographic data form, routine biochemical follow up data of patients, Toronto Alexithymia Scale (TAS), and Hospital Depression and Anxiety Scale (HADS) were used in this study. The statistical significance level was determined as p0.05). The results showed that increased incidence of depression resulted in a 4.47-fold (p=0.035) increase in the incidence of alexithymia. Conclusion: Alexithymia has been found to be high in patients with chronic kidney disease. Therefore, it is essential that we be aware of patients’ emotional stress and assess them for depression, anxiety, and alexithymia.
- Open Access
- 1 January 2023
- Published by Kare Publishing in Hepatology Forum
- Vol. 4 (1) , 14-18
Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
Background & Aim: Metabolic dysfunction-associated fatty liver disease (MAFLD) is expected to be prevalent among kidney transplant recipients (KTR). In this study, we evaluated the prevalence of MAFLD among KTRs, a data that has not been investigated by any clinical study to date. Matherials and Methods: We included a total of 52 KTRs and 53 age-, sex-, and BMI-matched individuals as control group through a prospective consecutive recruitment. We detected the presence of hepatic steatosis and liver fibrosis using controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) defined by FibroScan. Results: Among the KTRs, 18 (34.6%) had metabolic syndrome. The prevalence of MAFLD among the KTRs and controls was 42.3% and 51.9%, (p=0.375). The CAP and LSM values did not differ significantly between the KTRs and controls (p=0.222 and p=0.119). Among the KTRs, patients with MAFLD had significantly higher age, BMI, waist circumference, LDL, and total cholesterol levels (p
- 1 January 2023
- Published by Kare Publishing in Hepatology Forum
- Vol. 4 (1) , 14-18
Open AccessPrevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan
Background & Aim: Metabolic dysfunction-associated fatty liver disease (MAFLD) is expected to be prevalent among kidney transplant recipients (KTR). In this study, we evaluated the prevalence of MAFLD among KTRs, a data that has not been investigated by any clinical study to date. Matherials and Methods: We included a total of 52 KTRs and 53 age-, sex-, and BMI-matched individuals as control group through a prospective consecutive recruitment. We detected the presence of hepatic steatosis and liver fibrosis using controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) defined by FibroScan. Results: Among the KTRs, 18 (34.6%) had metabolic syndrome. The prevalence of MAFLD among the KTRs and controls was 42.3% and 51.9%, (p=0.375). The CAP and LSM values did not differ significantly between the KTRs and controls (p=0.222 and p=0.119). Among the KTRs, patients with MAFLD had significantly higher age, BMI, waist circumference, LDL, and total cholesterol levels (p